CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor by Furuta Takahisa, Sugimoto Mitsushige, Shirai Naohito, Ishizaki Takashi in Pharmacogenomics (2007).

[PMID: 17924835] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.